Free
Case Reports  |   March 2000
Reversal of Intraoperative Myocardial Ischemia with a Hemoglobin-based Oxygen Carrier
Author Affiliations & Notes
  • Marc Niquille, M.D.
    *
  • Marc Touzet, M.D.
  • Isabelle Leblanc, M.D.
  • Jean-François Baron, M.D.
    §
  • *Research Fellow. †Staff Anesthesiologist. ‡Resident. §Professor.
Article Information
Case Reports
Case Reports   |   March 2000
Reversal of Intraoperative Myocardial Ischemia with a Hemoglobin-based Oxygen Carrier
Anesthesiology 3 2000, Vol.92, 882. doi:
Anesthesiology 3 2000, Vol.92, 882. doi:
THE hemoglobin-based oxygen-carrying solutions currently under investigation have oxygen transport and exchange properties similar to blood. However, their cardiovascular effects are still a subject of controversy. In particular, there have been several reports of extensive vasonconstriction, 1–4 and several authors have suggested that this effect may be deleterious for the myocardium in patients with coronary artery disease. 5,6 
Case Report
A 64 yr-old man with abdominal aortic occlusive disease was admitted for an occlusion of the right lower limb of an aortobifemoral graft. The patient had previously undergone several radiologic and surgical lower-limb revascularization procedures. The patient reported an uncomplicated myocardial infarction after a previous aortobifemoral grafting procedure. However, there was no subsequent angina or cardiac insufficiency. On admission, his electrocardiogram showed a atrial fibrillation longstanding with a ventricular rate of 90 beats/min. Intravenous heparin was started but was complicated by a significant lower gastrointestinal hemorrhage leading to a decrease in hemoglobin concentration from 15.5 to 11.7 g/dl. Endoscopic exploration of the gastrointestinal tract failed to reveal a precise cause, but bleeding ceased. The patient was scheduled for a revision aortobifemoral graft.
Before surgery, the patient was enrolled in a randomized, single-blind, erythrocyte-controlled trial to evaluate the efficacy and the safety of an hemoglobin-based oxygen carrier (HBOC-201). The patient was informed of all risks and potential benefits, and written informed consent was obtained. The patient was not enrolled in a predonation program and was not treated with erythropoietin.
Anesthesia was induced using titrated doses of fentanyl, propofol, and atracurium. A pulmonary artery catheter was inserted, revealing high pulmonary capillary wedge pressure (25 mmHg). Anesthesia was maintained using a continuous infusion of propofol and intermittent fentanyl. Surgery was uneventful until aortic cross-clamping. During cross-clamping, the patient developed progressive systolic and diastolic hypotension to 80/50 mmHg (fig. 1) associated with new 2-mm ST-T segment depression on monitored standard leads II and V5. Pulmonary capillary wedge pressure remained at 25 mmHg. A dobuta-mine (6 μg · kg−1· min−1) and nitroglycerin (0.5 μg · kg−1· min−1) infusion was started. Blood pressure and heart rate increased (fig. 1) but with no improvement in ST-segment depression. Hemoglobin concentration at this point was 7.6 g/dl, and the decision to transfuse blood was made. In accordance with the trial protocol, the patient was randomly assigned to receive 60 g (500 ml) of HBOC-201. After the start of the infusion, systemic arterial blood pressure slightly increased and heart rate decreased with rapid normalization of the ST-T segment (fig. 1). Dobutamine and nitroglycerin infusions were stopped, and surgery was completed. During the postoperative period, recurrent tachycardia and ST-T changes were successfully treated by a second infusion of 30 g HBOC-201. On postoperative day 1, total hemoglobin was 11.3 g/dl with a plasma-free hemoglobin level of 2.2 g/dl. Troponin Ic levels remained normal, and the patient was discharged to the ward. On postoperative day 6, a new episode of gastrointestinal hemorrhage was observed. Total hemoglobin decreased from 9.0 to 7.4 g/dl, and 60 g HBOC-201 was infused without adverse events. Reexploration of the gastrointestinal tract revealed four small benign rectal polyps that were removed.
Fig. 1. Partial reproduction of the anesthetic chart. Induction = induction of anesthesia; SAP = systolic arterial pressure; DAP = diastolic arterial pressure; PCWP = pulmonary capillary wedge pressure; X clamp = aortic cross-clamping.
Fig. 1. Partial reproduction of the anesthetic chart. Induction = induction of anesthesia; SAP = systolic arterial pressure; DAP = diastolic arterial pressure; PCWP = pulmonary capillary wedge pressure; X clamp = aortic cross-clamping.
Fig. 1. Partial reproduction of the anesthetic chart. Induction = induction of anesthesia; SAP = systolic arterial pressure; DAP = diastolic arterial pressure; PCWP = pulmonary capillary wedge pressure; X clamp = aortic cross-clamping.
×
On postoperative day 2, moderate jaundice with a transient increase in AST (493 UI/l; normal values = 15–48 UI/l), ALT (121 UI/l; normal values = 10–40 UI/l), and lipase (120 UI/l; normal values = 7–60 UI/l) was noted. These returned to baseline within 3 days, without clinical or ultrasound evidence of hepatic or pancreatic lesion. The patient was discharged home on postoperative day 28 with a hematocrit of 37% and total hemoglobin of 11.6 g/dl without receiving allogenic packed erythrocytes or erythropoietin therapy.
Discussion
Hemoglobin-based oxygen carrier 201 is an intravenous solution of glutaraldehyde-polymerized bovine hemoglobin. Cardiovascular effects of HBOC-201 are still a subject of controversy because it has been demonstrated that isovolumic exchange during acute normovolemic hemodilution may result in decreased cardiac output associated with peripheral vasoconstriction. 3,4 Several investigators have stressed that this effect may be deleterious, especially in patients with coronary artery disease. 5,6 
This high-risk patient with cardiac and vascular disease experienced intraoperative myocardial ischemia likely related to anemia, hypotension, and tachycardia. The infusion of HBOC-201 led to a rapid hemodynamic improvement with normalization of ST-T segment abnormalities. This beneficial effect may have been related either to the cardiovascular effects of HBOC-201 or to its ability to improve tissue oxygenation.
Hemoglobin-induced vasoconstriction may result in reduced blood flow to vital organs and severe pulmonary hypertension. 7 It has been suggested that this vasoconstrictive effect may be mediated in part by endothelin, inhibition of nitric oxide, and sensitization of peripheral α receptors. 8 The magnitude of this vasoconstrictive effect seems to be attenuated by polymerization of hemoglobin either by glutaraldehyde 9 as HBOC-201 or o  -raffinose. 10 The effect of polymerization is likely caused by surface modification and/or intramolecular cross-linking, rather than an increase in molecular size limiting extravasation. 9 The consequences of the vasoconstrictive effect of HBOC on coronary circulation is also unclear. Early studies performed with incompletely purified hemoglobin solutions described coronary vasoconstriction. 11–13 More recent studies 14,15 have used modified, highly purified, and heat pasteurized hemoglobin-based solutions (diaspirin cross-linked). Infusion of diaspirin cross-linked hemoglobin increases blood pressure as well as blood flow to the myocardium and gastrointestinal tract. An endothelin receptor antagonist (phosphoramidon) could attenuate the systemic hemodynamic effects and some regional circulatory effects of diaspirin cross-linked hemoglobin. However, the increase in blood flow to the myocardium could not be modified by an endothelin receptor antagonist. Accordingly, in our case report, it may be suggested that cardiovascular effects of HBOC-201 may have contributed to the improvement in the hemodynamic status of the patient by increasing arterial pressure, coronary perfusion pressure, and decreasing heart rate. However, we cannot rule out the possibility that the same effects could have been accomplished with another colloid.
In addition, when compared with blood, HBOCs could improve tissue oxygenation more significantly. Standl et al.  16 compared the effects of stored erythrocytes, freshly donated blood, and HBOC-201 on muscular tissue oxygenation after extreme isovolemic hemodilution in a canine model. At a hematocrit of 10%, skeletal muscle tissue oxygen tension was decreased by approximately 50%. After transfusion, an increase of 0.7 g/dl of hemoglobin using HBOC-201 resulted in restoration of baseline tissue oxygenation. An increase in hemoglobin of 2.7 and 2.1 g/dl with fresh and stored blood, respectively, were needed to restore normal tissue oxygenation. These results demonstrate a higher oxygenation potential of HBOC as compared with fresh or stored erythrocytes in relation with better oxygen extraction. 16 The right shift of the oxygen–hemoglobin dissociation curve (P5032–35 mmHg) and a better distribution of blood oxygen-carrying capacity at the microcirculatory level are the main mechanisms explaining the improvement of tissue oxygenation. 17,18 Whether this played a role in the event observed in our patient is unknown.
In this patient, infusion of HBOC-201 was followed by a mild increase of AST, ALT, and lipase levels. However, there were not clinically significant and returned to baseline values rapidly. Such alterations have been reported in patients exposed to HBOC-201 in previous phase I and II studies, but its clinical relevance remains unknown. The increase in AST was greater than that of ALT and could also be related, in part, to the surgical procedure. The jaundice is explained by the interstitial diffusion and catabolism of the free hemoglobin.
References
Caron A, Menu P, Faivre-Fiorina B, Labrude P, Alayash AI, Vigneron C: Cardiovascular and hemorheological effects of three modified human hemoglobin solutions in hemodiluted rabbits. J Appl Physiol 1999; 86:541–8Caron, A Menu, P Faivre-Fiorina, B Labrude, P Alayash, AI Vigneron, C
Dietz NM, Martin CM, Beltran-del-Rio AG, Joyner MJ: The effects of cross-linked hemoglobin on regional vascular conductance in dogs. Anesth Analg 1997; 85:265–73Dietz, NM Martin, CM Beltran-del-Rio, AG Joyner, MJ
Kasper SM, Walter M, Grune F, Bischoff A, Erasmi H, Buzello W: Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996; 83:921–7Kasper, SM Walter, M Grune, F Bischoff, A Erasmi, H Buzello, W
Kasper SM, Grune F, Walter M, Amr N, Erasmi H, Buzello W: The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1998; 87:284–91Kasper, SM Grune, F Walter, M Amr, N Erasmi, H Buzello, W
Lee R, Neya K, Svizzero TA, Vlahakes GJ: Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 1995; 79:236–42Lee, R Neya, K Svizzero, TA Vlahakes, GJ
Hess JR: Review of modified hemoglobin research at Letterman: Attempts to delineate the toxicity of cell-free tetrameric hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1995; 23:277–89Hess, JR
de Figueiredo LF: Vasoactive properties of synthetic blood substitutes. Medicina 1998; 58:403–10de Figueiredo, LF
Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122:301–8Schultz, SC Grady, B Cole, F Hamilton, I Burhop, K Malcolm, DS
Doyle MP, Apostol I, Kerwin BA: Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties. J Biol Chem 1999; 274:2583–91Doyle, MP Apostol, I Kerwin, BA
Lieberthal W, Fuhro R, Freedman JE, Toolan G, Loscalzo J, Valeri CR: O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin. J Pharmacol Exp Ther 1999; 288:1278–87Lieberthal, W Fuhro, R Freedman, JE Toolan, G Loscalzo, J Valeri, CR
Macdonald VW, Motterlini R: Vasoconstrictor effects in isolated rabbit heart perfused with bis(3,5- dibromosalicyl)fumarate cross-linked hemoglobin (alpha alpha Hb). Artif Cells Blood Substit Immobil Biotechnol 1994; 22:565–75Macdonald, VW Motterlini, R
Hess JR, Macdonald VW, Gomez CS, Coppes V: Increased vascular resistance with hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 1994; 22:361–72Hess, JR Macdonald, VW Gomez, CS Coppes, V
Biro GP, Taichman GC, Lada B, Keon WJ, Rosen AL, Sehgal LR: Coronary vascular actions of stroma-free hemoglobin preparations. Artif Organs 1988; 12:40–50Biro, GP Taichman, GC Lada, B Keon, WJ Rosen, AL Sehgal, LR
Gulati A, Singh R, Chung SM, Sen AP: Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats. J Lab Clin Med 1995; 126:559–70Gulati, A Singh, R Chung, SM Sen, AP
Gulati A, Sharma AC, Singh G: Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 1996; 24:137–47Gulati, A Sharma, AC Singh, G
Standl T, Horn P, Wilhelm S, Greim C, Freitag M, Freitag U, Sputtek A, Jacobs E, Schulte am Esch J: Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs. Can J Anaesth 1996; 43:714–23Standl, T Horn, P Wilhelm, S Greim, C Freitag, M Freitag, U Sputtek, A Jacobs, E Schulte am Esch, J
Horn EP, Standl T, Wilhelm S, Jacobs EE, Freitag U, Freitag M, Schulte am Esch J: Bovine hemoglobin increases skeletal muscle oxygenation during 95% artificial arterial stenosis. Surgery 1997; 121:411–8Horn, EP Standl, T Wilhelm, S Jacobs, EE Freitag, U Freitag, M Schulte am Esch, J
Homer LD, Weathersby PK, Kiesow LA: Oxygen gradients between red blood cells in the microcirculation. Microvasc Res 1981; 22:308–23Homer, LD Weathersby, PK Kiesow, LA
Fig. 1. Partial reproduction of the anesthetic chart. Induction = induction of anesthesia; SAP = systolic arterial pressure; DAP = diastolic arterial pressure; PCWP = pulmonary capillary wedge pressure; X clamp = aortic cross-clamping.
Fig. 1. Partial reproduction of the anesthetic chart. Induction = induction of anesthesia; SAP = systolic arterial pressure; DAP = diastolic arterial pressure; PCWP = pulmonary capillary wedge pressure; X clamp = aortic cross-clamping.
Fig. 1. Partial reproduction of the anesthetic chart. Induction = induction of anesthesia; SAP = systolic arterial pressure; DAP = diastolic arterial pressure; PCWP = pulmonary capillary wedge pressure; X clamp = aortic cross-clamping.
×